HealthSprint 2026: Indo-Israel Innovation Sprint for Healthcare Startups — Frequently Asked Questions

HealthSprint 2026 is a 30-day innovation sprint run by GINSERV that brings Indian healthcare and medtech startups together with Israeli health-tech expertise to accelerate growth and investment readiness.

The programme does not offer direct funding or equity investment. It provides a fully sponsored visit to Israel, mentorship, hospital network access, investor engagement opportunities, and other growth support.

The deadline to apply is 20 July 2026.

HealthTech and MedTech startups based in Karnataka, Tamil Nadu, Kerala, or Puducherry—with a post-MVP product (TRL 6+), early revenue, and a solution in Clinical AI & Diagnostics, MedTech & Point-of-Care Devices, or Hospital SaaS & Managed Care Platforms.

No, the eligibility criteria do not mention DPIIT or MSME registration.

No, HealthSprint 2026 does not take equity. It is a growth and acceleration programme, not an investment fund.

Only 15 high-potential startups are selected to join the sprint.

Applications typically require your company profile, team résumés, pitch deck, evidence of post-MVP status (like a product demo or case studies), proof of early revenue, and a description of how your solution fits the focus areas.

Applications are submitted through the GINSERV community portal at the official HealthSprint 2026 page: https://community.ginserv.in/programs/apply/hea4828/healthsprint

HealthSprint 2026: Indo-Israel Innovation Sprint for Healthcare Startups is offered by GINSERV, an academic institution. It is provided as non-dilutive funding.

Apply directly through the official application link on this page. Review the eligibility criteria and prepare your startup documents before you begin.